Show simple item record

dc.contributor.authorMathieu, François
dc.contributor.authorGüting, Helge
dc.contributor.authorGravesteijn, Benjamin
dc.contributor.authorMonteiro, Miguel
dc.contributor.authorGlocker, Ben
dc.contributor.authorKornaropoulos, Evgenios N
dc.contributor.authorKamnistas, Konstantinos
dc.contributor.authorRobertson, Claudia S
dc.contributor.authorLevin, Harvey
dc.contributor.authorWhitehouse, Daniel P
dc.contributor.authorDas, Tilak
dc.contributor.authorLingsma, Hester F
dc.contributor.authorMaegele, Marc
dc.contributor.authorNewcombe, Virginia
dc.contributor.authorMenon, David K
dc.contributor.authorCollaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Investigators and Participants
dc.date.accessioned2020-04-09T23:30:46Z
dc.date.available2020-04-09T23:30:46Z
dc.date.issued2020-10-01
dc.identifier.issn0897-7151
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/304254
dc.description.abstractAn increasing number of elderly patients are being affected by traumatic brain injury (TBI) and a significant proportion are on pre-hospital antithrombotic therapy for cardio- or cerebrovascular indications. We have quantified the impact of antiplatelet/anticoagulant (APAC) agents on radiological lesion progression in acute TBI, using a novel, semi-automated approach to volumetric lesion measurement, and explored the impact of use on clinical outcomes in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. We used a 1:1 propensity-matched cohort design, matching controls to APAC users based on demographics, baseline clinical status, pre-injury comorbidities, and injury severity. Subjects were selected from a pool of patients enrolled in CENTER-TBI with computed tomography (CT) scan at admission and repeated within 7 days of injury. We calculated absolute changes in volume of intraparenchymal, extra-axial, intraventricular, and total intracranial hemorrhage (ICH) between scans, and compared volume of hemorrhagic progression, proportion of patients with significant degree of progression (>25% of initial volume), proportion with new ICH on follow-up CT, as well as clinical course and outcomes. A total of 316 patients were included (158 APAC users; 158 controls). The mean volume of progression was significantly higher in the APAC group for extra-axial (3.1 vs. 1.3 mL, p = 0.01), but not intraparenchymal (3.8 vs. 4.6 mL, p = 0.65), intraventricular (0.2 vs. 0.0 mL, p = 0.79), or total intracranial hemorrhage (ICH; 7.0 vs. 6.0 mL, p = 0.08). More patients had significant hemorrhage growth (54.1 vs. 37.0%, p = 0.003) and delayed ICH (4 of 18 vs. none; p = 0.04) in the APAC group compared with controls, but this was not associated with differences in length of stay (LOS), rates of neurosurgical intervention, mortality or Glasgow Outcome Scale Extended (GOS-E) score at 6 months. Pre-injury use of antithrombotic agents was associated with greater expansion of extra-axial lesions, higher rates of significant hemorrhagic progression, and higher risk of delayed traumatic ICH, but this was not associated with worse clinical course or functional outcomes.
dc.description.sponsorshipData used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). FM has received salary support for dedicated research time from the Canada Cambridge Scholarship funded by the Cambridge Commonwealth Trust. VN is supported by an Academy of Medical Sciences / The Health Foundation Clinician Scientist Fellowship. These studies were also supported by infrastructure provided by the NIHR Cambridge Biomedical Research Centre (BRC) is a partnership between Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge, funded by the National Institute for Health Research (NIHR). In addition, DKM was supported by an NIHR Senior Investigator Award. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
dc.format.mediumPrint-Electronic
dc.languageeng
dc.publisherMary Ann Liebert Inc
dc.rightsAll rights reserved
dc.subjectCollaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Investigators and Participants
dc.titleImpact of Antithrombotic Agents on Radiological Lesion Progression in Acute Traumatic Brain Injury: A CENTER-TBI Propensity-Matched Cohort Analysis.
dc.typeArticle
prism.endingPage2080
prism.issueIdentifier19
prism.publicationDate2020
prism.publicationNameJ Neurotrauma
prism.startingPage2069
prism.volume37
dc.identifier.doi10.17863/CAM.51334
dcterms.dateAccepted2020-04-02
rioxxterms.versionofrecord10.1089/neu.2019.6911
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2020-10
dc.contributor.orcidNewcombe, Virginia [0000-0001-6044-9035]
dc.identifier.eissn1557-9042
rioxxterms.typeJournal Article/Review
pubs.funder-project-idAcademy of Medical Sciences (unknown)
pubs.funder-project-idEuropean Commission (602150)
cam.orpheus.successMon Apr 27 07:59:13 BST 2020 - Embargo updated
cam.orpheus.counter2
rioxxterms.freetoread.startdate2021-04-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record